Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Liangzhen Dong"'
Autor:
Haoran Zhang, Zhetao Zheng, Liangzhen Dong, Ningning Shi, Yuelin Yang, Hongmin Chen, Yuxuan Shen, Qing Xia
Publikováno v:
Computational and Structural Biotechnology Journal, Vol 20, Iss , Pp 4930-4941 (2022)
The unnatural amino acid (UAA) incorporation technique through genetic code expansion has been extensively used in protein engineering for the last two decades. Mutations into UAAs offer more dimensions to tune protein structures and functions. Howev
Externí odkaz:
https://doaj.org/article/707a7d7488aa49618032d0206996aac1
Autor:
Zhujun Jiang, Haishuang Lin, Haoran Zhang, Ningning Shi, Zhetao Zheng, Liangzhen Dong, Yuelin Yang, Qing Xia
Publikováno v:
Vaccines, Vol 10, Iss 6, p 878 (2022)
Currently, an inactivated vaccine has been widely used with encouraging results as a prophylactic agent against COVID-19 infection, which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its variants. However, in vitro SA
Externí odkaz:
https://doaj.org/article/bdb252072d234617a06b408670ff24d4
Publikováno v:
Theranostics. 12:5317-5329
Human pluripotent stem cell derived brain organoids offer an unprecedented opportunity for various applications as
Autor:
Ningning Shi, Le Tong, Haishuang Lin, Zhetao Zheng, Haoran Zhang, Liangzhen Dong, Yuelin Yang, Yuxuan Shen, Qing Xia
Publikováno v:
Advanced biology. 6(11)
Site-specific incorporation of distinct noncanonical amino acids (ncAAs) into proteins via genetic code expansion in mammalian cells represents a new avenue for protein engineering. Reassigning three TAGs with the same ncAA in mammalian cells has pre
Human pluripotent stem cell (hPSC)-derived brain organoids offer an unprecedented opportunity for various applications as an in vitro model, such as modeling virus infection and drug screening. In this study, we present an experimental brain organoid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::52530c09f32188ec754fe8ceacf94766
https://doi.org/10.1101/2022.03.02.482634
https://doi.org/10.1101/2022.03.02.482634
Autor:
Hui Wang, Yaling Hu, Shunjia Zhang, Liangzhen Dong, Qing Xia, Xing Meng, Zhetao Zheng, Ying-Mei Feng, Ningning Shi, Li Su, Qiang Gao, Haoran Zhang, Haishuang Lin, Zhujun Jiang, Yudong Liu
Publikováno v:
SSRN Electronic Journal.
Background: Safe and effective vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are urgently needed to halt the spread of coronavirus disease 2019 (COVID-19) pandemic. As a promising inactivated SARS-CoV-2 vaccine, Corona